EYLEA Trademark

Trademark Overview

On Monday, May 10, 2021, a trademark application was filed for EYLEA with the United States Patent and Trademark Office. The USPTO has given the EYLEA trademark a serial number of 90701063. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, September 16, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The EYLEA trademark is filed in the Medical Instrument Products category with the following description:

Syringes for medical purposes and for injections; injection device for pharmaceuticals; injection needles
eylea

General Information

Serial Number90701063
Word MarkEYLEA
Filing DateMonday, May 10, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesSyringes for medical purposes and for injections; injection device for pharmaceuticals; injection needles

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 10, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Thursday, May 13, 2021NEW APPLICATION ENTERED
Tuesday, January 11, 2022ASSIGNED TO EXAMINER
Wednesday, January 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 13, 2022SOU EXTENSION 1 FILED
Tuesday, September 13, 2022SOU EXTENSION 1 GRANTED
Tuesday, September 13, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 2 FILED
Friday, March 31, 2023SOU EXTENSION 2 GRANTED
Tuesday, April 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU EXTENSION 3 FILED
Tuesday, October 10, 2023SOU EXTENSION 3 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 8, 2024SOU EXTENSION 4 GRANTED
Monday, April 8, 2024SOU EXTENSION 4 FILED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2024SOU EXTENSION 5 GRANTED
Tuesday, September 17, 2024SOU EXTENSION 5 FILED

Related Keywords

eylea injection device needles pharmaceuticals injections medical purposes syringes